Product Information
ABSORICA 30 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $37.8906 per EA under NDC 10631011731. Its NADAC has been published 575 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631011731
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISOTRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA021951On Market Since
6/8/2012
Pharmacological Classes
Price Statistics
The NADAC for ABSORICA 30 MG CAPSULE has been published 575 times since Nov 28, 2013, and over the history we have for it it has risen 67.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.8906 per EA |
|---|---|
| All-time high | $38.5233 (Sep 11, 2024) |
| All-time low | $22.6539 (Nov 28, 2013) |
| 52-week high | $38.4348 |
| 52-week low | $37.7155 |
| Median price | $36.5495 |
| Average price | $34.0297 |
| Largest weekly change | +12.0% (May 13, 2015) |
| Weeks tracked | 575 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABSORICA 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ABSORICA 30 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $37.8906 per EA (NDC 10631011731), effective Jun 24, 2026.
How has the price of ABSORICA 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ABSORICA 30 MG CAPSULE has risen 67.3%. It has been tracked across 575 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABSORICA 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ABSORICA 30 MG CAPSULE has ranged from a low of $22.6539 (Nov 28, 2013) to a high of $38.5233 (Sep 11, 2024), with a median of $36.5495 per EA.
Are there cheaper alternatives to ABSORICA 30 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, AMNESTEEM 30 MG CAPSULE, is $2.0993 per EA — about 94% below ABSORICA 30 MG CAPSULE.
Who manufactures ABSORICA 30 MG CAPSULE?
ABSORICA 30 MG CAPSULE (NDC 10631011731) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification